A comparison of two robotic platforms to screen plateletpheresis donors for HLA antibodies as part of a transfusion-related acute lung injury mitigation strategy

Transfusion

Volumn 50, Issue 8, 2010, Pages 1766-1777

  Vassallo, Ralph R ^a,b,c   Hsu, Susan ^a,b,c   Einarson, Mindy ^a,b,c   Barone, Jonathan ^a,b,c   Brodsky, Jaye ^a,b,c   Moroff, Gary ^a,b,c  

^a AMERICAN RED CROSS   (United States)

^b Quality Analytics   (United States)

^c HOLLAND LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIBODY; ALLOANTIBODY; HLA ANTIGEN;

ADOLESCENT; ADULT; AGED; ANALYZER; ANTIBODY DETECTION; ANTIBODY SCREENING; ANTIBODY SPECIFICITY; ARTICLE; BLOOD DONOR; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; INTERMETHOD COMPARISON; MALE; ROBOTICS; SEX DIFFERENTIATION; THROMBOCYTOPHERESIS; TRANSFUSION RELATED ACUTE LUNG INJURY; BLOOD; COMPARATIVE STUDY; DONOR SELECTION; IMMUNOLOGY; MIDDLE AGED; PROCEDURES;

ADOLESCENT; ADULT; AGED; DONOR SELECTION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HLA ANTIGENS; HUMANS; ISOANTIBODIES; MALE; MIDDLE AGED; PLATELETPHERESIS; ROBOTICS;

EID: 77955127866     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2010.02626.x     Document Type: Article

References (43)

1. Eder AF, Herron R, Strupp A, Dy B, Notari EP, Chambers LA, Dodd RY, Benjamin RJ. Transfusion-related acute lung injury surveillance (2003-2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross. Transfusion 2007 47 : 599 607.
2. Toy P, Popovsky MA, Abraham E, Ambruso DR, Holness LG, Kopko PM, McFarland JG, Nathens AB, Silliman CC, Stroncek D National Heart, Lung and Blood Institute Working Group on TRALI. Transfusion-related acute lung injury: definition and review. Crit Care Med 2005 33 : 721 6.
3. Kleinman S, Caulfield T, Chan P, Davenport R, McFarland J, McPhedran S, Meade M, Morrison D, Pinsent T, Robillard P, Slinger P. Toward an understanding of transfusion-related lung injury: statement of a consensus panel. Transfusion 2004 44 : 1774 89.
4. Triulzi D. Transfusion-related acute lung injury: current concepts for the clinician. Anesth Analg 2009 108 : 770 6.
5. Popovsky MA, Abel MD, Moore SB. Transfusion-related acute lung injury associated with passive transferred antileukocyte antibodies. Am Rev Respir Dis 1983 128 : 185 9.
6. Popovsky MA, Moore SB. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion 1985 25 : 573 7.
7. Stillman CC, McLaughlin NJ. Transfusion-related acute lung injury. Blood Rev 2006 20 : 139 59.
8. Bux J, Becker F, Seeger W, Kilpatrick D, Chapman J, Waters A. Transfusion-related acute lung injury due to HLA-A2-specific antibodies in recipient and NB-1 specific antibodies in donor blood. Br J Haematol 1996 93 : 707 13.
9. Kopko PM, Popovsky MA, Mackenzie MR, Paglieroni TG, Muto KN, Holland PV. HLA Class II antibodies in transfusion-related acute lung injury. Transfusion 2001 41 : 1244 8.
10. Kao GS, Wood IG, Dorfman DM, Milford EL, Benjamin RJ. Investigations into the role of anti-HLA Class II antibodies in TRALI. Transfusion 2003 43 : 185 91.
11. Maslanka K, Michur H, Zupanska B, Uhrynowska M, Nowak J. Leukocyte antibodies in blood donors and a look back on recipients of their blood components. Vox Sang 2007 92 : 247 9.
12. Davoren A, Curtis BR, Shulman IA, Mohrbacher AF, Bux J, Kwiatkowska BJ, McFarland JG, Aster RH. TRALI due to granulocyte-agglutinating human neutrophil antigen - 3a (5b) alloantibodies in donor plasma: a report of 2 fatalities. Transfusion 2003 43 : 641 5.
13. Toy P, Sun J, Hollis-Perry M, Jun J, Nakagawa M. Recipients of blood from a donor with multiple HLA antibodies. A blinded, lookback study of TRALI. Transfusion 2004 44 : 1683 8.
14. Munitz M, Sheldon S, Schuller RM, Young NS, Klein HG, Leitman SF, Stroncek DF. Patient-specific transfusion-related acute lung injury. Vox Sang 2008 94 : 70 3.
15. Zupanska B, Uhrynowska M, Michur H, Maslanka K, Zajko M. Transfusion-related acute lung injury and leukocyte-reacting antibodies. Vox Sang 2007 93 : 70 7.
16. Popovsky MA, Haley NR. Further characterization of transfusion-related acute lung injury: demographics, clinical and laboratory features, and morbidity. Immunohematology 2000 16 : 157 9.
17. Win N, Massey E, Lucas G, Sage D, Brown C, Green A, Contreras M, Navarrete C. Ninety-six suspected transfusion related acute lung injury cases: investigation findings and clinical outcome. Hematology 2007 12 : 461 9.
18. Stainsby D, Jones H, Knowles S, Chapman C, Davison K, Gray A, Cohen H, Boncinelli A, Birchall J, Milkins C, Brant L. Serious Hazards of Transfusion, 2004 Annual Report [cited 2010 Feb 25]. Available from: URL : http://www.shot-uk.org/SHOTREPORT2004.pdf
19. Sachs UJ, Link E, Hofmann C, Wasel W, Bein G. Screening of multiparous women to avoid transfusion-related acute lung injury: a single centre experience. Transfus Med 2008 18 : 348 54.
20. Reil A, Keller-Stanislawski B, Günay S, Bux J. Specificities of leucocyte alloantibodies in transfusion-related acute lung injury and results of leucocyte antibody screening of blood donors. Vox Sang 2008 95 : 313 7.
21. Middleburg RA, vanStein D, Briet E, van der Bom JG. The role of donor antibodies in the pathogenesis of transfusion-related acute lung injury: a systematic review. Transfusion 2008 48 : 2167 76.
22. Stroncek DF, Fadeyi E, Adams S. Leukocyte antigen and antibody detection assays: tools for assessing and preventing pulmonary transfusion reactions. Transfus Med Rev 2007 21 : 273 86.
23. MacLennan S, Lucas G, Brown C, Evans R, Kallon D, Brough S, Contreras M, Navarrete C. Prevalence of HLA and HNA antibodies in donors: correlation with pregnancy and transfusion history. Vox Sang 2004 87 Suppl 3 : 4.
24. Triulzi D, Kakaiya R, Schreiber G. Donor risk factors for white blood cell antibodies associated with transfusion-related acute lung injury REDS II Leukocyte Antibody Prevalence Study. Transfusion 2007 47 : 563 4.
25. Triulzi DJ, Kleinman S, Kakaiya RM, Busch MP, Norris PJ, Steele WR, Glynn SA, Hillyer CD, Carey P, Gottschall JL, Murphy EL, Rios JA, Ness PM, Wright DJ, Carrick D, Schreiber GB for the Retrovirus Epidemiology in Donor Study II. The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy. Transfusion 2009 49 : 1825 35.
26. Einarson M, Vassallo R, Moroff G, Barone J, Ponisciak M, Jakows S, Quinn M, Stearns F, Forey J, Murray C, Hsu S. HLA Class I antibody specificity in apheresis donors. Transfusion 2008 48 Suppl : 250A.
27. Looney MR, Su X, Van Ziffle JA, Lowell CA, Madhay MA. Neutrophils and their Fcγ receptors are essential in a mouse model of transfusion-related acute lung injury. J Clin Invest 2006 116 : 1615 23.
28. Dykes A, Smallwood D, Kotsimbos T, Treet A. Transfusion related acute lung injury (TRALI) in a patient with a single lung transplant. Br J Haematol 2000 109 : 674 6.
29. AABB Association Bulletin 06-07. Transfusion-related acute lung injury, 2006 cited 2010 Feb 25]. Available from: URL: http://www.aabb.org/Content/ Members-Area/Association-Bulletins/ab06-07.htm
30. Gajic O, Rana R, Winters J, Yilmaz M, Mendez JL, Rickman OB, O'Byrne MM, Evenson LK, Malinchoc M, DeGoey SR, Afessa B, Hubmayr RD, Moore SB. Transfusion-related acute lung injury in the critically ill: prospective nested case control study. Am J Respir Crit Care Med 2007 176 : 886 91.
31. Nishimura M, Hashimoto S, Takanashi M, Okazaki H, Satake M, Nakajima K. Role on anti-human leukocyte antigen Class II alloantibody and monocytes in development of transfusion-related acute lung injury. Transfus Med 2007 17 : 129 34.
32. Chapman CE, Stainsby D, Jones H, Love E, Massey E, Win N, Navarrete C, Lucas G, Soni N, Morgan C, Choo L, Cohen H, Williamson LM Serious Hazards of Transfusion Steering Group. Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma. Transfusion 2009 49 : 440 52.
33. Dunn P, Dinesh D. Transfusion-related acute lung injury (TRALI): a review of investigations by the National Tissue Typing Laboratory of cases reported in New Zealand since June 2004. N Z Med J 2008 121 : 42 7.
34. Eder AF, Benjamin RJ. TRALI risk reduction: donor and component management strategies. J Clin Apher 2009 24 : 122 9.
35. Domen RE, Casey H, Gaspari J. Correlation of HLA donor specific antibody (DSA) titers with Luminex mean fluorescence intensity (MFI). Hum Immunol 2008 69 Suppl 1 : S35.
36. Mizutani K, Terasaki P, Hamdani E, Esquenazi V, Rosen A, Miller J, Ozawa M. The importance of anti-HLA-specific antibody strength in monitoring kidney transplant patients. Am J Transplant 2007 7 : 1027 31.
37. Morrales-Buenrostro LE, Terasaki PI, Marino-Vazquez LA, Lee J, El-Awar NR, Alberu JS. "Natural" HLA antibodies in non-alloimmunized healthy males. Transplantation 2008 86 : 1111 5.
38. Alberu J, Morales-Buenrostro LE, de Leo C, Vargas-Rojas MI, Marino-Vazquez LA, Crispin JC. A non-allogeneic stimulus triggers the production of de novo HLA antibodies in healthy adults. Transplant Immunol 2007 18 : 166 71.
39. Fadeyi E, Adams S, Peterson B, Hackett J, Byrne P, Klein HG, Marincola FM, Leitman SF, Stroncek DF. Analysis of a high-throughput HLA antibody screening assay for use with platelet donors. Transfusion 2008 48 : 1174 9.
40. Powers A, Stowell CP, Dzik WH, Saidman SL, Lee H, Makar RS. Testing only donors with a prior history of pregnancy or transfusion is a logical and cost-effective transfusion-related acute lung injury prevention strategy. Transfusion 2008 48 : 2549 58.
41. Tongio MM, Falkenrodt A, Mitsuishi Y, Urlacher A, Bergerat JP, North ML, Mayer S. Natural HLA antibodies. Tissue Antigens 1985 26 : 271 85.
42. Sasaki N, Idica A, Terasaki PI. Mimetic human leukocyte antigen epitopes: shown by monoclonal antibodies and extra antibodies produced on transplantation. Transplantation 2008 86 : 912 8.
43. Cai J, Terasaki PI, Anderson N, Lachmann N, Schönemann C. Intact HLA not β2m-free heavy chain-specific HLA Class I antibodies are predictive of graft failure. Transplantation 2009 88 : 226 30.